Skip to main content

People in the News: Sep 28, 2010


OncoMethylome Sciences this week appointed Melissa Thompson as vice president of regulatory affairs and quality assurance, and Christopher Thibodeau as vice president of commercial operations.

Thompson has provided consultative services to a number of pharmaceutical and biotech companies in the past, including Affymetrix, Signature Genomics, and Exonhit Therapeutics.

Thibodeau joins OncoMethylome from Agendia, where he was senior director of marketing. He held similar positions at Numira Biosciences, US Labs, and Ventana Medical.

Huron Technologies, a Waterloo, Canada-based digital pathology and microarray tools company, recently announced a new management team after Confocal acquired a controlling interest in the firm.

Savvas Chamberlain has been named acting CEO. Chamberlain founded imaging firm Dalsa in 1980 and served as its CEO until 2007. He now is chairman of its board. In addition to Chamberlain's appointment, Mike Panayi has been named chief financial officer; Audil Virk has been appointed chief operating officer; Savvas Damaskinos is now chief technology officer; and Ted Dixon has been appointed vice president of science and technology.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.